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1. Normal pH-metry excludes the diagnosis with 95% certainty  (Alternative B).
2. The number of diagnoses is similar between the two procedures (Alternative D).
3. The prevalence of GERD in patients with atypical symptoms is 63.4% (Alternative A).
4. Biopsy allows the diagnosis of GERD non-responsive to treatment (Alternative D).
5. In asthmatic patients with reflux symptoms, normal pH-metry predicts therapeutic unresponsiveness  
    (Alternative C).
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1. What is the contribution of a therapeutic test with a proton pump inhibitor in the diagnosis of a patient with 
     GERD?
a. The test performed with omeprazole 40 mg results in a sensitivity of 98%.
b. The test performed with esomeprazole 20 mg results in a sensitivity of 79%.
c. The symptomatic response is superior to the treatment prior to the endoscopy.
d. The response with rabeprazole 20 mg results in a sensitivity of 99%.
2. Are the proton pump inhibitors different in the therapeutic response in GERD?
a. There are more patients cured with esomeprazole than with pantoprazole.
b. Esomeprazole 20/40 mg is superior to lansoprazole 30 mg.
c. In pyrosis lansoprazole 30 mg is similar to omeprazole 20 mg.
d. In erosive esophagitis olansoprazole 30 mg is superior to omeprazole 20 mg.
3. In GERD, must the proton pump inhibitor be used in a single dose or in two daily intakes?
a. Rabeprazole 10 mg in two intakes increase the severity of the symptoms.
b. Esomeprazole 20 mg (two intakes) is superior to 40 mg (one intake).
c. Esomeprazole 40 mg once a day heals lesions more effectively.
d. The clinical response of two intakes is superior to that of a single dose.
4. In GERD, must the type 2 histamine blocker be associated to the proton pump inhibitor?
a. The addition of an H2 blocker does not improve the symptoms. 
b. Nocturnal association of ranitidine to PPI aids to the control of gastric acidity.
c. The percentage of time with pH > 4 during the night is higher in the group with the association.
d. The addition of an H2 blocker leads to 43% improvement in symptoms
5. Does the chronic use of a proton pump inhibitor cause gastric diseases?
a. In patients who are HP positive, the use of omeprazole 20 mg for seven years produces glandular atrophy.
b. In one year of use of omeprazole 40 mg a day, the prevalence of protrusion of parietal cells decreases from 
86% to 18%.
c. Patients suffering from GERD who remained HP negative presented histological signs of gastric disease with 
chronic use.
d. HP eradication with the chronic use of PPI protects fundic glands.
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